Nanobiotix Stock Triples In Trading Session: What’s Going On With Stock On Friday – Nanobiotix (NASDAQ:NBTX)

  • Nanobiotix NBTX shares gained more than 200% on Friday trading after it entered into final contract negotiations with a major global pharmaceutical company.
  • In its Q4 earnings release, Nanobiotix raised going concerns.
  • The company noted net losses of €57.0 million in 2022 and a net decrease in cash and cash equivalents of €42.5 million in 2022. 
  • Nanobiotix stock is gaining on heavy volume, with a session volume of 30.262 million shares traded.
  • The company agreed to a non-binding term sheet for developing and commercializing lead nanotherapeutic candidate NBTXR3 with an undisclosed pharmaceutical company.
  • The arrangement is subject to negotiation and execution of a definitive agreement and each party’s requisite internal corporate approvals for the definitive terms.
  • Nanobiotix does not intend to make additional statements regarding negotiations unless and until it is appropriate to do so or a final definitive agreement has been signed.
  • Price Action: NBTX shares are up 244.8% at $7.00 on the last check Friday.

Source link